387 related articles for article (PubMed ID: 38732176)
41. Catastrophic APS in the context of other thrombotic microangiopathies.
Rodríguez-Pintó I; Espinosa G; Cervera R
Curr Rheumatol Rep; 2015 Jan; 17(1):482. PubMed ID: 25604575
[TBL] [Abstract][Full Text] [Related]
42. [Summary of pathophysiology and diagnosis of patients with platelet abnormality].
Wada H; Asakura H
Rinsho Byori; 2009 May; 57(5):474-6. PubMed ID: 19522256
[TBL] [Abstract][Full Text] [Related]
43. Clinical Evaluation and Management of Thrombotic Microangiopathy.
Leisring J; Brodsky SV; Parikh SV
Arthritis Rheumatol; 2024 Feb; 76(2):153-165. PubMed ID: 37610060
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
45. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
46. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
[TBL] [Abstract][Full Text] [Related]
47. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
[TBL] [Abstract][Full Text] [Related]
48. [Diagnosis and treatment of microangiopathic hemolytic anemia].
Morishita E
Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
[TBL] [Abstract][Full Text] [Related]
49. Endothelial cells and thrombotic microangiopathy.
Motto D
Semin Nephrol; 2012 Mar; 32(2):208-14. PubMed ID: 22617770
[TBL] [Abstract][Full Text] [Related]
50. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
[TBL] [Abstract][Full Text] [Related]
51. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
52. Platelets: an update on diagnosis and management of thrombocytopenic disorders.
McCrae KR; Bussel JB; Mannucci PM; Remuzzi G; Cines DB
Hematology Am Soc Hematol Educ Program; 2001; ():282-305. PubMed ID: 11722989
[TBL] [Abstract][Full Text] [Related]
53. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.
Bommer M; Wölfle-Guter M; Bohl S; Kuchenbauer F
Dtsch Arztebl Int; 2018 May; 115(19):327-334. PubMed ID: 29875054
[TBL] [Abstract][Full Text] [Related]
54. Shiga Toxin as a Potential Trigger of CFHR1 Deletion-Associated Thrombotic Microangiopathy.
Nalluru SS; Sridharan M; Go RS; Said S; Marshall AL
Am J Med Sci; 2018 Nov; 356(5):492-498. PubMed ID: 30177262
[TBL] [Abstract][Full Text] [Related]
55. Thrombocytopenia: Evaluation and Management.
Gauer RL; Whitaker DJ
Am Fam Physician; 2022 Sep; 106(3):288-298. PubMed ID: 36126009
[TBL] [Abstract][Full Text] [Related]
56. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
57. Management of Vascular Thrombosis in Patients with Thrombocytopenia.
Voigtlaender M; Langer F
Hamostaseologie; 2022 Feb; 42(1):19-28. PubMed ID: 34933376
[TBL] [Abstract][Full Text] [Related]
58. Acute Pancreatitis as a Trigger for Thrombotic Microangiopathy: A Case Report.
Adragão F; Nabais I; Reis R; Pereira B; Ramos A
Cureus; 2021 Dec; 13(12):e20103. PubMed ID: 34993042
[TBL] [Abstract][Full Text] [Related]
59. Thrombotic Microangiopathy Syndrome in a Basic Underwater Demolition/SEAL Student.
Croom D; Tracy H
J Spec Oper Med; 2016; 16(3):16-19. PubMed ID: 27734437
[TBL] [Abstract][Full Text] [Related]
60. Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy.
Scully M
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):651-659. PubMed ID: 29222317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
